Cargando…
The Duration and Determinants of Anti-SARS-CoV-2 Immunoglobulin G in Cancer Patients with SARS-CoV-2 Infection: A Longitudinal Study
Patients with cancer have an increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and a high case-fatality rate. The duration of anti-SARS-CoV-2 immunoglobulin G (IgG) antibodies in cancer patients following SARS-CoV-2 infection has not been reported previously. W...
Autores principales: | Jiang, Yao, Zhao, Yingchao, Li, Guiling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242909/ https://www.ncbi.nlm.nih.gov/pubmed/35767154 http://dx.doi.org/10.1007/s00284-022-02933-2 |
Ejemplares similares
-
Duration of anti-SARS-CoV-2 antibodies much shorter in India
por: Kumar, Nishant, et al.
Publicado: (2021) -
SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
por: Abdelghany, T.M., et al.
Publicado: (2021) -
Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodies
por: Sekirov, Inna, et al.
Publicado: (2021) -
Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches
por: Stinca, Sara, et al.
Publicado: (2021) -
WHO International Standard for anti-SARS-CoV-2 immunoglobulin
por: Kristiansen, Paul A, et al.
Publicado: (2021)